Menu

Recent Interviews

Ryan Jackson, CEO, Newlox Gold Ventures Corp.

Ryan Jackson
CEO | Newlox Gold Ventures Corp.
60 Laurie Crescent, V7S 1B7 West Vancouver (CAN)

info@newloxgold.com

+1 778 738 0546

Newlox CEO Ryan Jackson on building a green gold producer with a rapid growth trajectory


Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


02. November 2020 | 09:07 CET

Ballard Power, Saturn Oil & Gas, Amazon - The profiteers of the crisis!

  • Covid-19
Photo credits: pixabay.com

The profiteers of the first wave of the Corona pandemic are seen from the most recently published quarterly figures. The well-known FAANG stocks Facebook, Amazon, Apple, Netflix and Alphabet (Google) were able to improve their balance sheets significantly. Besides some winners, the number of losers is much larger. These now either have to fight for survival or are swallowed cheaply by financially more robust competitors. The takeover wave should pick up speed in 2021, across all industries!

time to read: 2 minutes by Stefan Feulner


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


The pike in the carp pond

Due to the sharp drop in prices, there are also great opportunities in the oil market to grow disproportionately through acquisitions. The prerequisite is that you are blessed with cash and have already localized the possible takeover targets. For John Jeffrey, the experienced CEO and Chairman of Saturn Oil & Gas, the current circumstances are just perfect. For Jeffrey, it is clear that buying in competitors offers clear advantages over its own drilling program. The current market capitalization of the Canadians is currently at favorable EUR 15 million. Targeted acquisitions would take the Company into new dimensions.

Strategically sensible

Understandably, Jeffrey is keen not to produce at a much higher cost in the future than at present. In 2019, Saturn Oil & Gas was by far the cheapest oil producer in Canada. At only around USD 12 per barrel of oil, the production costs were significantly lower than those of the large, well-known oil producers, which had production costs of well over USD 30 per barrel.

Change in management indicates growth

Only yesterday, the news came in that Saturn Oil & Gas will continue to strengthen its position. Wendy Woolsey is joining the team headed by Jeffrey on an interim basis. Woolsey herself has more than 25 years of experience in the Canadian oil and gas industry. She served as Vice President, Finance and Chief Financial Officer of Yoho Resources Inc. from 2005 to 2016 and before that as Manager of Finance at Baytex Energy and Vice President, Finance and Chief Financial Officer of Symmetry Resources Inc. For Jeffrey, this is another coup and possibly a sign of further growth for Saturn Oil & Gas Inc. We can be excited about what will follow in the coming weeks.

Strong partnership

Good news at Ballard Power. The Canadians have reached a final agreement with the automotive giant Audi on the extended use of the FCgen HPS fuel cell stack. According to the press release, the marketing of the new fuel cell development can start worldwide and across all industries, including trucks and passenger cars. Previously, Ballard had only the right to use the stack for a limited number of applications, including bus, rail, marine, mining, construction, aviation and stationary power applications.

Caution advised

Despite the very positive news, caution is advised at one of the leading fuel manufacturers. After the ongoing strong correction, the resistance zone, which was successfully defended last week, has to hold at around CAD 16.50. If not, the next way would be the 200-day line, which currently runs at approx. CAD 13.50.

Unstoppable

One could guess that the figures for the third quarter would be positive. However, these even beat all analysts' estimates by a wide margin. Amazon increased its sales in the reporting period by 37% to USD 96.1 billion. Operating income rose to USD 6.2 billion, compared to USD 3.2 billion in the same period of the previous year. Earnings per share exploded to USD 12.37. Analysts had "only" expected proceeds of USD 93 billion, but they were clearly off target for earnings per share. They estimated this at only USD 7.41. With the recent lockdowns in almost all of Europe, nothing should stand in the way of an absolute record year.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

21. October 2020 | 12:42 CET | by Stefan Feulner

BioNTech, Valeo Pharma, Pfizer - Starting signal!

  • Covid-19

Who will make the race for the first approved Corona vaccine? Russia, China, and several North American suppliers are fighting for a place in the sun. The second and third parties should also benefit from the approval, as the demand is enormous among the nearly 8 billion inhabitants of the earth. One thing is clear; the winners of this almost macabre-sounding "Corona contest" will go through the roof. Those who receive late approval or no approval at all risk extinction. Admittedly, the world is looking at the long-awaited miracle cure. But there are easier ways for every individual to protect themselves against viruses.

Read

23. September 2020 | 09:05 CET | by Mario Hose

BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

  • Covid-19

When the Corona Pandemic started in November 2019 in Wuhan, China, nobody could have guessed the extent of the disease. Socially, economically and politically, Covid-19 has turned the world upside down. With increasing knowledge in dealing with the coronavirus, people around the globe are trying to come to terms with the new state of affairs - as best they can. On the stock market, there are numerous opportunities for investors to participate in further development in the fight against serious diseases.

Read

18. September 2020 | 06:00 CET | by Mario Hose

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

  • Covid-19

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and active ingredients are being sought to combat Covid-19. Above all, the common good of all is the primary focus of political institutions and for this reason they are not letting research-based companies down and are attracting them with special permits and subsidies. Ultimately, everyone around the world will likely benefit from this.

Read